Interpretation of clinical practice guidelines of diagnosis and treatment of hepatobiliary tumors: hepatocellular carcinoma and intrahepatic cholangiocarcinoma
10.3760/cma.j.cn115610-20231212-00251
- VernacularTitle:肝胆肿瘤临床诊疗实践系列指南解读：肝细胞癌和肝内胆管癌
- Author:
Mingliang SHI
1
;
Yang SHEN
;
Mingda WANG
;
Tian YANG
Author Information
1. 河南大学第一附属医院普通外科，开封 475001
- Keywords:
Liver neoplasms;
Primary;
Diagnosis;
Surgical Procedures, operative;
Peri-operative period;
Management;
Guideline;
Interpretation
- From:
Chinese Journal of Digestive Surgery
2024;23(2):188-196
- CountryChina
- Language:Chinese
-
Abstract:
Primary liver cancer is a highly malignant tumor of the digestive tract, charac-terized by an insidious onset and frequently accompanied by local progression or distant metastasis. Although surgical resection is typically the optimal treatment for patients with locally resectable tumors, the major challenge in achieving long-term survival prognosis lies in the high postoperative recurrence rate. Due to the substantial heterogeneity and complexity of primary liver cancer, a multimodal comprehensive treatment approach involving surgical resection, systemic therapy ( e.g., targeted therapy, chemotherapy, immunotherapy), and/or local treatment is commonly employed. As research regarding primary liver cancer continues to progress, it becomes crucial for surgical oncologists to acquire a deep understanding and proficiency in the latest surgical diagnostic and treatment methods, along with optimal patient selection and management strategies. The authors aim to comprehensively elaborate on the latest practice guidelines for surgically treatment of primary liver cancer and systematically outline the key points in evaluating primary liver cancer, primarily focusing on hepatocellular carcinoma and intrahepatic bile duct carcinoma, and offer pertinent recommendations for clinical treatment, thus providing robust evidence in the clinical management and decision-making for patients with primary liver cancer.
